Variant report
Variant | esv3513389 |
---|---|
Chromosome Location | chr5:57678195-57686993 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:57679618..57681387-chr5:57685117..57687190,2 | MCF-7 | breast: | |
2 | chr5:57679458..57681464-chr5:57685190..57686778,2 | MCF-7 | breast: | |
3 | chr5:57684855..57687554-chr5:57691257..57692769,2 | MCF-7 | breast: | |
4 | chr5:57679618..57681387-chr5:57685117..57687190,2 | MCF-7 | breast: | |
5 | chr5:57679458..57681464-chr5:57685190..57686778,2 | MCF-7 | breast: | |
6 | chr5:57685717..57687980-chr5:57753512..57756250,3 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000145632 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs35917227 | chr5:57678197-57678198 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs549345620 | chr5:57678216-57678217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs147641828 | chr5:57678231-57678232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537996813 | chr5:57678237-57678238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148702714 | chr5:57678276-57678277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs573490574 | chr5:57678277-57678278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538509754 | chr5:57678282-57678283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189080331 | chr5:57678297-57678298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs572110297 | chr5:57678370-57678371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs142160308 | chr5:57678377-57678378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554494152 | chr5:57678424-57678425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192827240 | chr5:57678456-57678457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs2561440 | chr5:57678560-57678561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs57114973 | chr5:57678564-57678565 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs184311169 | chr5:57678731-57678732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576938898 | chr5:57678734-57678735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545346103 | chr5:57678738-57678739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565440639 | chr5:57678803-57678804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532089212 | chr5:57678843-57678844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528004835 | chr5:57678884-57678885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs549552501 | chr5:57678891-57678892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs114202347 | chr5:57678922-57678923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs189035802 | chr5:57678923-57678924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549864186 | chr5:57678974-57678975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571279903 | chr5:57679036-57679037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs34040598 | chr5:57679070-57679071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs151204065 | chr5:57679090-57679091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs550243552 | chr5:57679110-57679111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs4700281 | chr5:57679148-57679149 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs547506635 | chr5:57679171-57679172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs139180287 | chr5:57679229-57679230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs374868460 | chr5:57679231-57679232 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565939331 | chr5:57679318-57679319 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs536198784 | chr5:57679356-57679357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs369490356 | chr5:57679361-57679362 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372745208 | chr5:57679365-57679366 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376985528 | chr5:57679366-57679367 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs6887561 | chr5:57679373-57679374 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs75304217 | chr5:57679399-57679400 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs6873644 | chr5:57679447-57679448 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541000533 | chr5:57679465-57679466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs140168024 | chr5:57679471-57679472 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs111877820 | chr5:57679473-57679474 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs370334832 | chr5:57679517-57679518 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs559133485 | chr5:57679552-57679553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs572690462 | chr5:57679586-57679587 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542959589 | chr5:57679590-57679591 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs59851734 | chr5:57679597-57679598 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12657414 | chr5:57679618-57679619 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs566303118 | chr5:57679704-57679705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:57677200-57689600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr5:57679200-57679600 | Enhancers | HMEC | breast |
3 | chr5:57679200-57679600 | Enhancers | NHEK | skin |
4 | chr5:57686200-57686400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr5:57686600-57687600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |